Larvol Delta - Safety-and-Efficacy-of-TareSphere-Injection-and-CTACE-in-Patients-with-Unresectable-HCC

NRT6003 - Chengdu New Radiomedicine Technology

http://clinicaltrials.gov/ct2/show/NCT06900543

Mar 28, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next